SCHEMBL22100568

SCHEMBL22100568

CC(C)n1c2ccc(N(c3ccccc3)c3ccccc3)cc2c2cc(-n3c4ccccc4c4ccccc43)ccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ NPY5R Q15761 5/20 0.39
▸ BCHE P06276 1/20 0.39
▸ ACHE P22303 1/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ ATM Q13315 2/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ RORC P51449 3/20 0.36
▸ MAPT P10636 2/20 0.33
▸ MAPK1 P28482 2/20 0.33
▸ TDP1 Q9NUW8 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ TSHR P16473 1/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ CASP7 P55210 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ RAC2 P15153 1/20 0.33
▸ RAC3 P60763 1/20 0.33
▸ CDC42 P60953 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16696177 0.91 MEN1 (0.51) MEN1KMT2ANPY5RBCHEACHE
SCHEMBL13301588 0.86 KDM4E (0.55) MEN1KMT2AKDM4EATML3MBTL1
SCHEMBL13301594 0.86 KDM4E (0.55) MEN1KMT2AKDM4EATML3MBTL1
SCHEMBL3331856 0.86 KDM4E (0.55) MEN1KMT2AKDM4EATML3MBTL1
SCHEMBL15730706 0.86 KDM4E (0.55) MEN1KMT2AKDM4EATML3MBTL1
SCHEMBL19485347 0.86 KDM4E (0.55) MEN1KMT2AKDM4EATML3MBTL1
SCHEMBL15887513 0.86 MEN1 (0.44) MEN1KMT2ANPY5RBCHEACHE
SCHEMBL10299033 0.86 MEN1 (0.55) MEN1KMT2ANPY5RBCHEACHE
SCHEMBL21454580 0.86 MEN1 (0.55) MEN1KMT2ANPY5RBCHEACHE
SCHEMBL18056652 0.86 MEN1 (0.55) MEN1KMT2ANPY5RBCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200190100-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2020-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200190100-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME OCIAD1, OCIAD2, DRD1 MEN1 2405/4885KMT2A 3226/4885NPY5R 3876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback